Prohibiting the Administration of Stanozolol to Racehorses
NY-ADR
3/16/16 N.Y. St. Reg. SGC-52-15-00007-A
NEW YORK STATE REGISTER
VOLUME XXXVIII, ISSUE 11
March 16, 2016
RULE MAKING ACTIVITIES
NEW YORK STATE GAMING COMMISSION
NOTICE OF ADOPTION
I.D No. SGC-52-15-00007-A
Filing No. 263
Filing Date. Mar. 01, 2016
Effective Date. Mar. 16, 2016
Prohibiting the Administration of Stanozolol to Racehorses
PURSUANT TO THE PROVISIONS OF THE State Administrative Procedure Act, NOTICE is hereby given of the following action:
Action taken:
Amendment of sections 4043.15 and 4020.12 of Title 9 NYCRR.
Statutory authority:
Racing, Pari-Mutuel Wagering and Breeding Law, sections 103(2), 104(1), (19), 301(1), (2) and 902(1)
Subject:
Prohibiting the administration of stanozolol to racehorses.
Purpose:
To preserve the safety and integrity of pari-mutuel racing while generating reasonable revenue for the support of government.
Text or summary was published
in the December 30, 2015 issue of the Register, I.D. No. SGC-52-15-00007-P.
Final rule as compared with last published rule:
No changes.
Text of rule and any required statements and analyses may be obtained from:
Kristen Buckley, New York State Gaming Commission, One Broadway Center, P.O. Box 7500, Schenectady, New York 12301, (518) 388-3407, email: [email protected]
Initial Review of Rule
As a rule that does not require a RFA, RAFA or JIS, this rule will be initially reviewed in the calendar year 2021, which is no later than the 5th year after the year in which this rule is being adopted.
Assessment of Public Comment
One public comment was received in response to the publication of the proposed rule-making in the December 30, 2015 State Register. A veterinarian wrote that stanozolol should be permitted subject to drug testing for appropriate use because stanozolol is a useful medicine when used appropriately. The Commission disagrees with this suggestion because current laboratory testing cannot readily distinguish between appropriate and other uses of this drug. In addition, the proposal will continue to permit the use of three endogenous anabolic steroids, which are efficacious and have a much shorter clearance time, for necessary therapy while a horse is restricted from racing.
| End of Document |